How have DMT shares performed in 2024?

Small Pharma's stock was trading at C$0.15 at the start of the year. Since then, DMT shares have increased by 0.0% and is now trading at C$0.15. View the best growth stocks for 2024 here .

How do I buy shares of Small Pharma?

Shares of DMT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:DMT

Small Pharma (DMT) Stock Price, News & Analysis

→ IRS Loophole Gives Americans An Escape From Inflation (From Birch Gold) (Ad)

Free DMT Stock Alerts

C$0.15

-0.01 (-6.25%)

(As of 10/20/2023)

Compare

Today's Range: C$0.15
▼
C$0.16
50-Day Range: C$0.15
▼
C$0.15
52-Week Range: C$0.06
▼
C$0.22

Volume: 1.89 million shs
Average Volume: 296,159 shs
Market Capitalization: C$50.37 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Headlines Insider Trades

Get Small Pharma alerts:

Ad Birch Gold

IRS Loophole Gives Americans An Escape From Inflation

In the years immediately following 2008-09, as the economy stagnated, gold exploded in value. Today, Goldman Sachs is telling its clients that gold may reach $2,250 within the next few years. Don't miss your chance to diversify your savings.

Request your info kit on gold now

About Small Pharma Stock (CVE:DMT)

Small Pharma Inc., a biotechnology company, focuses on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions. Its clinical program is based on N,N, dimethyltryptamine, a naturally occurring psychoactive molecule. The company's product includes SPL026, which is in clinical Phase IIa for the treatment of major depressive disorder; and SPL028, an injectable formulation of deuterated DMT, which is in Phase 1 clinical trial, as well as SPL801B, an oral dosage. Its preclinical stage programs include SPL029, an oral formulation of a tryptamine to treat depressive disorder. The company is headquartered in London, the United Kingdom. As of October 23, 2023, Small Pharma Inc. operates as a subsidiary of Cybin Inc.

DMT Stock Price History

30 days | 90 days | 365 days | Advanced Chart

DMT Stock News Headlines

April 10, 2024 | forbes.com

Navigating The Cookieless Era: How Pharma Adapts To Continual Disruption

April 10, 2024 | americanbankingnews.com

Small Pharma (CVE:DMT) Stock Price Down 6.3%

April 18, 2024 | Birch Gold (Ad)

IRS Loophole Gives Americans An Escape From Inflation

April 8, 2024 | msn.com

FSD Pharma receives Nasdaq notification regarding minimum bid price deficiency

March 26, 2024 | finance.yahoo.com

Juvisé Pharmaceuticals Acquires Multiple Sclerosis Drug PONVORY® (ex-US/Canada) and Opens Its Capital to Bpifrance and Pemberton

March 13, 2024 | msn.com

LGM Pharma unveils enhanced analytical testing services and expands CDMO portfolio with additional suppository manufacturing capabilities

March 9, 2024 | businessinsider.com

Pharmaceutical companies behind weight-loss drugs are slimming down a new target: The Magnificent 7

February 27, 2024 | msn.com

Pharma major Roche launches breakthrough therapy to treat Multiple Sclerosis in India

April 18, 2024 | Birch Gold (Ad)

IRS Loophole Gives Americans An Escape From Inflation

February 20, 2024 | msn.com

Trxade sells online pharma marketplace, stock rallies 90%

February 15, 2024 | msn.com

Medford Massachusets Move To Decriminalize Psychedelics Has Statewide Reform Implications

December 5, 2023 | msn.com

Small Pharma Tackles Major Depression with Potentially Game Changing Psychedelic Therapy

October 23, 2023 | finance.yahoo.com

Canadian Investment Regulatory Organization Trading Halt - DMT

October 20, 2023 | benzinga.com

Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business

October 20, 2023 | finanznachrichten.de

Small Pharma Inc.: Small Pharma Reports Fiscal Second Quarter 2024 Highlights

October 17, 2023 | theglobeandmail.com

Closing Bell: Small Pharma Inc down on Monday (DMT)

October 12, 2023 | markets.businessinsider.com

Small Pharma Announces Voting Results from Annual General and Special Meeting of Shareholders

October 3, 2023 | theglobeandmail.com

Closing Bell: Small Pharma Inc up on Monday (DMT)

September 28, 2023 | theglobeandmail.com

Closing Bell: Small Pharma Inc down on Wednesday (DMT)

August 28, 2023 | finance.yahoo.com

Canadian Investment Regulatory Organization Trade Resumption - DMT

August 26, 2023 | theglobeandmail.com

Closing Bell: Small Pharma Inc up on Friday (DMT)

August 25, 2023 | theglobeandmail.com

Closing Bell: Small Pharma Inc down on Thursday (DMT)

July 28, 2023 | finanznachrichten.de

Small Pharma Inc.: Small Pharma Reports Fiscal First Quarter 2024 Highlights

July 28, 2023 | finance.yahoo.com

Small Pharma Reports Fiscal First Quarter 2024 Highlights

July 5, 2023 | msn.com

Small Pharma Implements Costs Cut: New R&D Strategy And Management Team Change

July 5, 2023 | finance.yahoo.com

Small Pharma Announces SPL028 R&D Strategy Update

July 5, 2023 | benzinga.com

Small Pharma Announces Management Team Change

See More Headlines

Receive DMT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Small Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: CVE:DMT
CUSIP: N/A
CIK: N/A
Web: www.smallpharma.co.uk
Phone: 44 78 1212 1944
Fax: N/A
Employees: 13
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): C($0.07)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: C$-19,310,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -116.90%
Return on Assets: -66.00%

Debt

Debt-to-Equity Ratio: 5.95
Current Ratio: 2.63
Quick Ratio: 6.28

Sales & Book Value

Annual Sales: C$-1,162.00
Price / Sales: -43,343.80
Cash Flow: C$0.13 per share
Price / Cash Flow: 1.13
Book Value: C$0.03 per share
Price / Book: 5.00

Miscellaneous

Outstanding Shares: 335,770,000
Free Float: N/A
Market Cap: C$50.37 million
Optionable: Not Optionable
Beta: 0.86

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. George Tziras
CEO & Non-Independent Director
Mr. David Steel
Chief Financial Officer
Dr. Carol Routledge
Chief Scientific & Medical Officer
Ms. Marie Claire Layzell (Age 46)
Chief Manufacturing & Development Officer & Director
Comp: $457.93k
Dr. Alastair James Riddell M.D. (Age 74)
M.Sc., MBChB, MFPM, MRCGP, Ph.D., Chief Operating Officer
Ms. Jenny Maguire
Head of Brand & Communications
Ms. Emma Hodge
Head of Intellectual Property
Mr. Richard M. Kimel HBA (Age 56)
LLB, Corporate Secretary
Ms. Sarah Hamilton
Group Financial Controller
Mr. Jim Rennie
Director of Development and Member of Scientific & Advisory Board

Key Competitors

View All Competitors

Insiders

Peter David Rands
Sold 638,000 shares
Total: C$43,511.60 ($0.07/share)

View All Insider Transactions

DMT Stock Analysis - Frequently Asked Questions

How have DMT shares performed in 2024?: Small Pharma's stock was trading at C$0.15 at the start of the year. Since then, DMT shares have increased by 0.0% and is now trading at C$0.15.
View the best growth stocks for 2024 here.
How do I buy shares of Small Pharma?: Shares of DMT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:DMT) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Small Pharma (DMT) Stock Price, News & Analysis

About Small Pharma Stock (CVE:DMT)

DMT Stock Price History

DMT Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

DMT Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info